Literature DB >> 19035293

Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells.

Masamichi Mizuma1, Yu Katayose, Kuniharu Yamamoto, Satoru Shiraso, Tsuyoshi Sasaki, Shinichi Yabuuchi, Akira Oda, Kunihiro Masuda, Toshiki Rikiyama, Tohru Onogawa, Hideo Ohtsuka, Fuyuhiko Motoi, Shinichi Egawa, Michiaki Unno.   

Abstract

BACKGROUND: p27Kip1 is a cyclin-dependent kinase inhibitor which has been reported to be associated with invasion, metastasis and angiogenesis in malignant tumors, but its mechanism of action remains unknown. Here, it was examined whether p27Kip1 has an inhibitory effect on cancer cell invasion and correlates with matrix metalloproteinase expression (MMPs).
MATERIAL AND METHODS: The human breast cancer cell line MDA-MB-231 and MDA-MB-231 transfectedp27Kip1 MDA-MB-p27 were used for the invasion assay, Western blotting and real-time quantitative RT-PCR.
RESULTS: In the invasion assay, the invasion of MDA-MB-p27 was significantly less than that of the parent cell line. In Western blotting analyses, the protein level of MMP-9 was also reduced in MDA-MB-p27. Furthermore, the activity of MMP-9 in cell culture supernatants was lower in MDA-MB-p27 as compared with enzyme-linked immunosorbent assays. In real-time quantitative RT-PCR, the mRNA level of MMP-9 was lower in MDA-MB-p27 cells.
CONCLUSION: Up-regulation of p27Kip1 remarkably inhibited the invasion of the breast cancer cells, in part due to the reduced expression of MMP-9. This is the first report of p27Kip1 modulating MMP-9 and indicating that p27Kip1 might play a key role in tumor cell invasion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19035293

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes.

Authors:  A H Thomson; J McGrane; J Mathew; J Palmer; D A Hilton; G Purvis; R Jenkins
Journal:  Br J Cancer       Date:  2016-02-23       Impact factor: 7.640

2.  Identification of exosomal miR-455-5p and miR-1255a as therapeutic targets for breast cancer.

Authors:  Ying Xin; Xueqiang Wang; Kexin Meng; Chao Ni; Zhenye Lv; Dandan Guan
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.